Fernandez-Diaz Oscar F, Christopoulos Georgios, Griffiths Matthew
From the St. Andrew's Centre for Plastic Surgery and Burns, Broomfield Hospital, Chelmsford, UK.
Group for Academic Plastic Surgery, Blizard Institute, Queen Mary University of London, London, UK.
Plast Reconstr Surg Glob Open. 2023 May 17;11(5):e4969. doi: 10.1097/GOX.0000000000004969. eCollection 2023 May.
Recipient vessel selection is vital for successful autologous free-flap breast reconstruction. Internal mammary artery perforators have gained interest as a recipient vessel option. However, previous studies on their microsurgical safety and efficacy are limited and inconsistent. Thus, we conducted a systematic review and meta-analysis to assess the safety and effectiveness of using internal mammary artery perforators as recipient vessels in breast reconstruction.
The protocol has been previously published in PROSPERO (CRD42020190020). The PubMed, Scopus, Web of Science, and PROSPERO databases were searched. Two independent reviewers evaluated the articles for inclusion in the study. Study quality was assessed using the Newcastle-Ottawa Scale and the MINORS instrument (Methodological Index for Non-Randomized Studies).
Of the 361 articles screened, 13 studies were included (313 patients with 318 flaps; 223 unilateral, 31 bilateral, mean average age 51.2 and mean BMI 27.8 ± 1.9). The mean overall success rate was 99.8%, the pooled surgical success rate was 100% [95% confidence interval (CI): 97%-100%], and the overall rate of complications was 11% (95% CI: 7%-18%). The most common complication was vascular-related to microanastomoses, with an incidence of 5% (95% CI: 2%-10%). The fat necrosis rate was 3% (95% CI: 2%-6%).
This study verified that internal mammary artery perforator vessels are reliable in breast reconstruction, with a high success rate and a relatively low complication rate. Moreover, in selected microsurgical breast reconstruction patients, internal mammary artery perforators may be the primary recipient vessel choice over the internal mammary artery or thoracodorsal vessels.
受区血管的选择对于自体游离皮瓣乳房重建的成功至关重要。胸廓内动脉穿支作为受区血管选择已引起关注。然而,先前关于其显微外科安全性和有效性的研究有限且不一致。因此,我们进行了一项系统评价和荟萃分析,以评估在乳房重建中使用胸廓内动脉穿支作为受区血管的安全性和有效性。
该方案先前已发表于国际前瞻性系统评价注册库(CRD42020190020)。检索了PubMed、Scopus、Web of Science和国际前瞻性系统评价注册库数据库。两名独立的评审员评估文章是否纳入研究。使用纽卡斯尔-渥太华量表和MINORS工具(非随机研究方法学指数)评估研究质量。
在筛选的361篇文章中,纳入了13项研究(313例患者,318个皮瓣;223例单侧,31例双侧,平均年龄51.2岁,平均体重指数27.8±1.9)。总体成功率平均为99.8%,汇总手术成功率为100%[95%置信区间(CI):97%-100%],并发症总发生率为11%(95%CI:7%-18%)。最常见的并发症是与微血管吻合相关的血管并发症,发生率为5%(95%CI:2%-10%)。脂肪坏死率为3%(95%CI:2%-6%)。
本研究证实胸廓内动脉穿支血管在乳房重建中是可靠的,成功率高且并发症发生率相对较低。此外,在选定的显微外科乳房重建患者中,胸廓内动脉穿支可能比胸廓内动脉或胸背血管更适合作为首选的受区血管。